Brief: Context Therapeutics Reports Full Year 2024 Operating And Financial Results
20/03/2025 21:02
March 20 (Reuters) - Context Therapeutics Inc CNTX.O: CONTEXT THERAPEUTICS REPORTS FULL YEAR 2024 OPERATING AND FINANCIAL RESULTS CONTEXT THERAPEUTICS: CO EXPECTS ITS CASH AND CASH EQUIVALENTS WILL CONTINUE TO FUND OPERATIONS INTO 2027 Source text: ID:nGNXcdy5yH Further company coverage: CNTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202